Phantomics
About Phantomics
Phantomics is a healthcare AI company dedicated to overcoming cardiovascular diseases through accurate and reliable AI-driven diagnostic imaging technologies. Founded in 2019, the company integrates advanced artificial intelligence with medical imaging to develop next-generation solutions capable of detecting disease biomarkers and predicting prognoses. Their mission is to revolutionize early detection and prevention of cardiovascular and other critical diseases, aiming to make state-of-the-art medical technologies accessible to every hospital worldwide.
The company’s flagship solution, Myomics, utilizes AI-powered, non-invasive cardiac MRI and CT analysis to provide rapid and accurate diagnostic results for myocardial diseases such as heart failure, myocarditis, and amyloidosis. Myomics is actively used in over 20 major general and secondary hospitals in South Korea, as well as in 19 international medical institutions, and has received regulatory approvals including U.S. FDA clearance. Phantomics is also expanding its research and development to include non-invasive diagnostic solutions for liver and muscle wasting diseases.
Phantomics aims to lower the barriers of cardiac MRI and CT examinations by providing standardized AI solutions, thereby creating a beneficial ecosystem for both medical professionals and patients. The company’s technology provides quantitative and precise disease diagnosis and prognosis prediction by comprehensively analyzing medical images and biomarkers, enabling physicians to make accurate decisions.
Focus Areas
Business Intelligence
| Key Investors | Devsisters Ventures, Bigbang Angels, COMEUP STARS, DAYLI Partners, Tech Incubator Program for Startup |
| Partnerships | GE HealthCare Korea, Philmedis Clinic, Yonsei University Severance Hospital, Siemens Healthineers Korea, Yujeong Meditech |
| Technology | AI-powered diagnostic platforms, advanced AI algorithms, image biomarker technology, cloud-native solutions, automated contour detection, quantitative analysis (ejection fraction, stroke volume, mass, wall motion, strain, T1/T2 mapping, tissue characterization, LGE quantification, flow assessment) |
| FDA Clearances | 2 cleared products (estimated) |
What Physicians Need to Know
Phantomics' solutions, like Myomics and Angiomics, offer physicians a 'virtual fellow' for faster, more accurate, and standardized cardiac imaging analysis. This can significantly reduce the burden of manual interpretation, improve diagnostic confidence, and enable earlier intervention for critical cardiovascular conditions. The non-invasive nature of their image biomarker technology provides a safer alternative to traditional invasive procedures like myocardial tissue biopsies. Physicians can leverage these tools to streamline workflows, enhance diagnostic capabilities even without immediate access to highly specialized experts, and ultimately improve patient outcomes through precise and timely diagnoses.
Phantomics' solutions are designed for seamless integration into existing healthcare IT infrastructure, including hospital information systems, and are accessible via web and mobile platforms. They are actively pursuing partnerships with medical imaging platform vendors and have a strategic MOU with GE HealthCare Korea to co-develop new product features and improve image quality and scan protocols, indicating strong potential for integration with various imaging equipment and PACS systems.
What the Web Says
Phantomics appears to be a company with a focus on medical imaging and AI, specifically in the cardiovascular space. While direct product reviews on major platforms like G2, Capterra, or even dedicated healthcare IT review sites are scarce, the company's LinkedIn presence and academic collaborations suggest a strong scientific foundation. Employer reviews are also not readily available on Glassdoor or Reddit, indicating it might be a smaller or less publicly reviewed entity.
Overall: MixedStrengths
- Focus on cutting-edge AI in cardiovascular imaging.
- Potential for significant impact in medical diagnostics.
- Likely strong scientific and technical expertise within the company.
- Collaborations with academic institutions (implied by research focus).
- Addresses a critical need in healthcare for improved diagnostics.
- Innovative approach to medical data analysis.
Limitations
- Lack of readily available product reviews on major platforms (G2, Capterra).
- Limited public information regarding customer satisfaction.
- Absence of employer reviews on Glassdoor or Reddit.
- Might be a relatively new or niche company, leading to less public discourse.
- Potential for long sales cycles typical in healthcare IT.
- High regulatory hurdles inherent in medical device/software development.
Based on reviews from: G2 (no direct reviews found), Glassdoor (no direct reviews found), Capterra (no direct reviews found), Healthcare IT reviewers (no specific reviews found, general industry knowledge applied), Reddit (no direct reviews found), LinkedIn (company profile, general industry presence)
Last updated: 2026-07-18
Videos
News, demos, and interviews about Phantomics.
Videos load interactively. If none appear, search YouTube for Phantomics →
Press & Coverage
Frequently Asked Questions
Related Companies
e4health is a healthcare consulting and services company that provides innovative solutions to hospitals, health systems, outpatient providers, and physician practices. The company focuses on addressing data, quality, and revenue challenges within the healthcare ecosystem. Their services are designed to streamline health information data and workflows, optimize coding, quality, and clinical documentation integrity processes, and […]
PayZen is a healthcare fintech company that leverages AI and automation to address the growing challenge of healthcare affordability for patients and financial stability for providers. The platform offers personalized, interest-free payment plans, extending up to 60 months, tailored to each patient’s ability to pay. This approach aims to remove financial barriers to care, allowing […]
Healthcare Finance.AI is dedicated to optimizing healthcare revenue cycles through cutting-edge AI technologies. The company aims to improve financial outcomes for healthcare providers while supporting their commitment to quality care and efficiency. Their solutions are designed to enhance revenue cycle efficiency, reduce claim turnaround times, and improve patient billing accuracy. Their platform leverages advanced analytics […]
The American Academy of Family Physicians (AAFP) is one of the largest national medical organizations in the United States, representing over 130,000 family physicians, residents, and medical students. Founded in 1947, its core mission is to improve the health of patients, families, and communities by serving the needs of its members with professionalism and creativity. […]
Imperial College Business School, a faculty of Imperial College London, is a leading institution that integrates business education with science, engineering, medicine, and technology. For physicians and healthcare providers, the Business School offers specialized programs and research focused on the intersection of AI, digital transformation, and healthcare management. Their curriculum is designed to equip healthcare […]
Columbia University, through its online learning initiative ColumbiaX on edX, offers a range of courses, including those focused on healthcare AI. The university is a global leader in research, teaching, and public impact, consistently ranked among top universities. Their online offerings reflect a commitment to academic excellence and expanding access to high-quality education worldwide. For […]